Here are three emerging digital health companies’ funding rounds:
- Nectar, a digital allergy treatment platform, raised $16.5 million in its series A financing round.
- Carallel, a company that provides digital tools to family caregivers, raised $8.2 million in a series A financing round led by FCA Venture Partners.
- Parallel Bio, a biotech company working to replicate the human immune system in a dish, raised $4.3 million in its seed financing round.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
